Advertisement

Journal of Industrial Microbiology

, Volume 13, Issue 5, pp 328–334 | Cite as

Inability of the human fecal microflora to metabolize the nonabsorbable fat substitute, olestra

  • Barbara A. Nuck
  • Thomas G. Schlagheck
  • Thomas W. Federle
Article

Summary

Olestra is a non-caloric fat substitute under review by the Food and Drug Administration. It consists of a mixture of octa-, hepta- and hexaesters of sucrose formed with long chain fatty acids. Previous studies showed olestra is not hydrolyzed by mammalian lipases and is not absorbed. The objective of this study was to evaluate the potential for colonic microflora to metabolize olestra after continued exposure. Neat and emulsified14C-[fatty acid] olestra was incubated for 72 h in both minimal and organically-enriched anaerobic media inoculated with feces from seven subjects who had consumed olestra (9 g per day) over a 3–4 week period.14C-sucrose and14C-glucose served as positive controls. Production of14CO2,14CH4,14C-volatile fatty acids (VFAs) and14C-long chain fatty acids (LCFAs) was determined. In addition, the ester distribution and fatty acid composition of olestra were examined before and after incubation. Significant quantities of14CO2 and14C-VFAs were generated from the14C-sugars, indicating that the microflora were active under the incubation conditions. Furthermore, free oleic acid was extensively hydroxylated and hydrogenated. In contrast, no degradation products (gas, VFAs, LCFAs) or changes in the olestra resulting from bacterial activity were detected. These results indicate that under anaerobic conditions the colonic microflora of the humans, consuming olestra, did not metabolize olestra.

Key words

GI microflora Bacterial catabolism Fat substitute Olestra 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eyssen, H.J. and G.G. Parmentier. 1974. Influence of the microflora of the rat on the metabolism of fatty acids, sterols and bile salts in the intestinal tract. Zbl. Bakt. Suppl. 7: 39–44.Google Scholar
  2. 2.
    Eyssen, H.J. and G.G. Parmentier. 1974. Biohydrogenation of sterols and fatty acids by the intestinal microflora. Am J. Clin. Nutr. 27: 1329–1340.PubMedGoogle Scholar
  3. 3.
    Fallat, R.W., C.J. Glueck, R. Lutmer and F.H. Mattson. 1976. Short term study of sucrose polyester a nonabsorbable fat-like material as a dietary agent for lowering plasma cholesterol. Am. J. Clin. Nutr. 29: 1204–1215.PubMedGoogle Scholar
  4. 4.
    Harris, B.E., B.W. Manning, T.W. Federle and R.B. Diasio. 1986. Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora. Antimicrob. Agents Chemother. 29: 44–48.PubMedGoogle Scholar
  5. 5.
    Manning, B.W., C.E. Cerniglia and T.W. Federle. 1986. Biotransformation of 1-nitropyrene to 1-aminopyrene by the human intestinal microflora. J. Toxicol. Environ. Health 18: 339–346.PubMedGoogle Scholar
  6. 6.
    Manning, B.W., T.W. Federle and C.E. Cerniglia. 1987. Use of semicontinuous culture system as a model for determining the rule of human intestinal microflora in the metabolism of xenobiotics. J. Microbiol. Methods 6: 81–94.Google Scholar
  7. 7.
    Mattson, F.H. and G.A. Nolen. 1972. Absorbability by rats of compounds containing from one to eight ester groups. J. Nutr. 102: 1171–1176.PubMedGoogle Scholar
  8. 8.
    Mattson, F.H. and R.A. Volpenheim. 1972. Hydrolysis of fully esterified alcohols containing from one to eight hydroxyl groups by the lipolytic enzymes of rat pancreatic juice. J. Lipid Res. 13: 325–328.PubMedGoogle Scholar
  9. 9.
    Mattson, F.H. and R.A. Volpenheim. 1972. Rate and extent of absorption of the fatty acids of fully esterified glycerol, erythritol, xylitol and sucrose as measured in thoracic duct cannulated rats. J. Nutr. 102: 1177–1180.PubMedGoogle Scholar
  10. 10.
    McInerney, M.J., M.P. Bryant and N. Pfennig. 1979. Anaerobic bacteria that degrades fatty acids in synthrophic association with methanogens. Arch. Microbiol. 122: 129–135.Google Scholar
  11. 11.
    Miller, T.L. and M.J. Wolin. 1981. Fermentation by the human large intestine microbial community in an in vitro semicontinuous culture system. Appl. Environ. Microbiol. 42: 400–407.PubMedGoogle Scholar
  12. 12.
    National Research Council. 1989. Diet and Health: Implications for Reducing Chronic Disease Risk. National Academy Press, Washington, DC.Google Scholar
  13. 13.
    Pearson, J.R., H.S. Wiggins and B.S. Drasar. 1974. Conversion of long-chain unsaturated fatty acids to hydroxy acids by human intestinal bacteria. J. Med. Microbiol. 7: 265–275.PubMedGoogle Scholar
  14. 14.
    Scheline, R.R. 1973. Metabolism of foreign compounds by gastrointestinal organisms. Pharmacol. Rev. 25: 451–523.PubMedGoogle Scholar
  15. 15.
    Spain, J.C., P.H. Pritchard and A.W. Bourquin. 1980. Effects of adaptation on biodegradation rates in sediment/water cores from estuarine and freshwater environments. Appl. Environ. Microbiol. 40: 726–734.Google Scholar
  16. 16.
    Thomas, P.J. 1972. Identification of some enteric bacteria which convert oleic acid to hydroxystearic acid in vitro. Gastroenterology 62: 430–435.PubMedGoogle Scholar
  17. 17.
    Weng, C.N. and J.S. Jeris. 1976. Biochemical mechanisms in the methane fermentation of glutamic and oleic acids. Water Res. 10: 9–18.Google Scholar
  18. 18.
    Wrong O.M., C.J. Edmonds and V.S. Chadwick. 1981. The Large Intestine: Its Role in Mammalian Nutrition and Homeostasis. John Wiley and Sons, New York.Google Scholar

Copyright information

© Society for Industrial Microbiology 1994

Authors and Affiliations

  • Barbara A. Nuck
    • 1
  • Thomas G. Schlagheck
    • 2
  • Thomas W. Federle
    • 1
  1. 1.Environmental Sciences Department, Corporate Professional and Regulatory Services DivisionThe Procter & Gamble Company, Ivorydale Technical CenterCincinnatiUSA
  2. 2.Regulatory and Clinical Development DivisionThe Procter & Gamble Company, Ivorydale Technical CenterCincinnatiUSA

Personalised recommendations